| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 6.99e-06 | 3 | 32 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | germ cell development | 8.54e-05 | 482 | 32 | 6 | GO:0007281 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 1.39e-04 | 527 | 32 | 6 | GO:0022412 | |
| GeneOntologyBiologicalProcess | learning or memory | 2.54e-04 | 373 | 32 | 5 | GO:0007611 | |
| GeneOntologyBiologicalProcess | learning | 3.11e-04 | 212 | 32 | 4 | GO:0007612 | |
| GeneOntologyBiologicalProcess | maintenance of location | 3.34e-04 | 396 | 32 | 5 | GO:0051235 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 4.45e-04 | 233 | 32 | 4 | GO:0050806 | |
| GeneOntologyBiologicalProcess | cognition | 4.52e-04 | 423 | 32 | 5 | GO:0050890 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 4.66e-04 | 931 | 32 | 7 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 4.66e-04 | 931 | 32 | 7 | GO:0007268 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 4.78e-04 | 663 | 32 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | negative regulation of synapse organization | 4.81e-04 | 21 | 32 | 2 | GO:1905809 | |
| GeneOntologyBiologicalProcess | cardiac myofibril assembly | 4.81e-04 | 21 | 32 | 2 | GO:0055003 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 4.82e-04 | 664 | 32 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 4.91e-04 | 939 | 32 | 7 | GO:0099537 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 6.18e-04 | 976 | 32 | 7 | GO:0099536 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 6.62e-04 | 259 | 32 | 4 | GO:0051651 | |
| Domain | NEBU | 1.70e-05 | 4 | 32 | 2 | SM00227 | |
| Domain | NEBULIN | 1.70e-05 | 4 | 32 | 2 | PS51216 | |
| Domain | Nebulin | 1.70e-05 | 4 | 32 | 2 | PF00880 | |
| Domain | Nebulin_repeat | 1.70e-05 | 4 | 32 | 2 | IPR000900 | |
| Domain | Nebulin | 1.70e-05 | 4 | 32 | 2 | IPR013998 | |
| Domain | RIH_assoc | 4.25e-05 | 6 | 32 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 4.25e-05 | 6 | 32 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 4.25e-05 | 6 | 32 | 2 | PF01365 | |
| Domain | RIH_dom | 4.25e-05 | 6 | 32 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.25e-05 | 6 | 32 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.25e-05 | 6 | 32 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 4.25e-05 | 6 | 32 | 2 | PF08709 | |
| Domain | - | 4.25e-05 | 6 | 32 | 2 | 1.25.10.30 | |
| Domain | MIR | 1.27e-04 | 10 | 32 | 2 | PS50919 | |
| Domain | MIR | 1.27e-04 | 10 | 32 | 2 | PF02815 | |
| Domain | MIR | 1.27e-04 | 10 | 32 | 2 | SM00472 | |
| Domain | MIR_motif | 1.27e-04 | 10 | 32 | 2 | IPR016093 | |
| Domain | ARM-type_fold | 2.57e-04 | 339 | 32 | 5 | IPR016024 | |
| Domain | Arm | 1.28e-03 | 31 | 32 | 2 | PF00514 | |
| Domain | ARM | 2.13e-03 | 40 | 32 | 2 | SM00185 | |
| Domain | ARM_REPEAT | 2.13e-03 | 40 | 32 | 2 | PS50176 | |
| Domain | Armadillo | 2.93e-03 | 47 | 32 | 2 | IPR000225 | |
| Domain | UBA-like | 5.37e-03 | 64 | 32 | 2 | IPR009060 | |
| Domain | SH3 | 5.91e-03 | 216 | 32 | 3 | PS50002 | |
| Domain | SH3 | 5.91e-03 | 216 | 32 | 3 | SM00326 | |
| Domain | SH3_domain | 6.22e-03 | 220 | 32 | 3 | IPR001452 | |
| Domain | - | 6.37e-03 | 222 | 32 | 3 | 1.25.10.10 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 9.44e-05 | 10 | 21 | 2 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.15e-04 | 11 | 21 | 2 | M49033 | |
| Pathway | WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS | 1.63e-04 | 13 | 21 | 2 | M39463 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.63e-04 | 13 | 21 | 2 | M47656 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.63e-04 | 13 | 21 | 2 | M39589 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.73e-04 | 74 | 21 | 3 | MM15962 | |
| Pathway | WP_GPR40_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M39526 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 2.50e-04 | 16 | 21 | 2 | M40060 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.56e-04 | 19 | 21 | 2 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 3.95e-04 | 20 | 21 | 2 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 4.36e-04 | 21 | 21 | 2 | M47689 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 4.80e-04 | 22 | 21 | 2 | M39795 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.80e-04 | 22 | 21 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.80e-04 | 22 | 21 | 2 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.25e-04 | 23 | 21 | 2 | M47676 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.29e-03 | 147 | 21 | 3 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.39e-03 | 151 | 21 | 3 | M39329 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.47e-03 | 154 | 21 | 3 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.53e-03 | 156 | 21 | 3 | M39475 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.79e-03 | 165 | 21 | 3 | MM15026 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 1.82e-03 | 166 | 21 | 3 | M16024 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.23e-03 | 178 | 21 | 3 | M2890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 2.48e-03 | 50 | 21 | 2 | M47951 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.89e-03 | 54 | 21 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.89e-03 | 54 | 21 | 2 | M27460 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.89e-03 | 54 | 21 | 2 | M26911 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.23e-03 | 203 | 21 | 3 | M5485 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.67e-03 | 61 | 21 | 2 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 3.79e-03 | 62 | 21 | 2 | M27321 | |
| Pubmed | 8.76e-08 | 638 | 32 | 8 | 31182584 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 33674626 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 25023003 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 22100703 | ||
| Pubmed | Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor. | 4.92e-06 | 4 | 32 | 2 | 17925404 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 30667096 | ||
| Pubmed | 6.44e-06 | 794 | 32 | 7 | 11076863 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.23e-05 | 6 | 32 | 2 | 16844763 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 23463619 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.23e-05 | 6 | 32 | 2 | 25966694 | |
| Pubmed | Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy. | 1.23e-05 | 6 | 32 | 2 | 30986853 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 11860456 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.29e-05 | 8 | 32 | 2 | 19033399 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 15623527 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 8.55e-05 | 15 | 32 | 2 | 28578927 | |
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 18824598 | ||
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 9.76e-05 | 16 | 32 | 2 | 24960163 | |
| Pubmed | 9.84e-05 | 97 | 32 | 3 | 25071155 | ||
| Pubmed | 1.11e-04 | 101 | 32 | 3 | 9872452 | ||
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 15967462 | ||
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 27521426 | ||
| Pubmed | Identification of Modifier Genes in a Mouse Model of Gaucher Disease. | 1.87e-04 | 22 | 32 | 2 | 27568557 | |
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 10843712 | ||
| Pubmed | 2.43e-04 | 25 | 32 | 2 | 21145499 | ||
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 28720576 | ||
| Pubmed | Same but different - Molecular comparison of human KTI12 and PSTK. | 2.84e-04 | 27 | 32 | 2 | 33417976 | |
| Pubmed | Integrating genetic and network analysis to characterize genes related to mouse weight. | 3.28e-04 | 29 | 32 | 2 | 16934000 | |
| Pubmed | 3.35e-04 | 147 | 32 | 3 | 29576527 | ||
| Pubmed | 4.75e-04 | 720 | 32 | 5 | 16381901 | ||
| Pubmed | 4.81e-04 | 722 | 32 | 5 | 15489336 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 4.95e-04 | 168 | 32 | 3 | 30631154 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 5.65e-04 | 38 | 32 | 2 | 30786075 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.59e-04 | 774 | 32 | 5 | 15302935 | |
| Pubmed | 6.71e-04 | 777 | 32 | 5 | 35844135 | ||
| Pubmed | 7.19e-04 | 191 | 32 | 3 | 20195357 | ||
| Pubmed | 8.64e-04 | 47 | 32 | 2 | 8812413 | ||
| Cytoband | 6q24.3 | 2.58e-05 | 11 | 32 | 2 | 6q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q23 | 6.34e-04 | 53 | 32 | 2 | chr2q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q24 | 1.37e-03 | 78 | 32 | 2 | chr6q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q25 | 3.79e-03 | 131 | 32 | 2 | chr10q25 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.21e-04 | 43 | 19 | 2 | 409 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 7.00e-07 | 139 | 32 | 5 | M6754 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | 5.60e-05 | 567 | 32 | 6 | M16909 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.66e-05 | 180 | 32 | 4 | M8239 | |
| Coexpression | GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN | 9.44e-05 | 197 | 32 | 4 | M9879 | |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN | 9.81e-05 | 199 | 32 | 4 | M9434 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 1.00e-04 | 200 | 32 | 4 | M7505 | |
| Coexpression | GSE2826_WT_VS_BTK_KO_BCELL_UP | 1.00e-04 | 200 | 32 | 4 | M4898 | |
| Coexpression | GSE27786_LSK_VS_CD4_TCELL_DN | 1.00e-04 | 200 | 32 | 4 | M4747 | |
| Coexpression | GHO_ATF5_TARGETS_UP | 1.12e-04 | 13 | 32 | 2 | M12008 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.25e-04 | 656 | 32 | 6 | M18979 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | 2.20e-04 | 459 | 32 | 5 | M39136 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 | 2.47e-04 | 471 | 32 | 5 | M3062 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.51e-07 | 654 | 32 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.16e-05 | 532 | 32 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.36e-05 | 232 | 32 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 7.99e-05 | 983 | 32 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 8.24e-05 | 493 | 32 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.22e-04 | 328 | 32 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-07 | 195 | 32 | 5 | 32ec72103faccc9e37c0ecedff1998e7df6a19f6 | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.86e-06 | 149 | 32 | 4 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 9.69e-06 | 188 | 32 | 4 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | |World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-05 | 121 | 32 | 3 | da8fe561dcf50792d0cbcaad383d564f900a6677 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-04 | 146 | 32 | 3 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-04 | 148 | 32 | 3 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-04 | 148 | 32 | 3 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 149 | 32 | 3 | a6406c4c9404271a2f4c615c6cd3265b2d759b12 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 151 | 32 | 3 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 151 | 32 | 3 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 154 | 32 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 154 | 32 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 154 | 32 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 154 | 32 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 155 | 32 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 155 | 32 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-04 | 159 | 32 | 3 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-04 | 159 | 32 | 3 | 1dde4d19cc0fde7ebbccb4c31bb845a92206021b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.03e-04 | 160 | 32 | 3 | 6de505bfe1fbbe984718740a9cf43d0e02ff452e | |
| ToppCell | Healthy_Control-Lymphoid-T-innate_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.22e-04 | 165 | 32 | 3 | 1ade67229b50fe20eb392262a3e1ee4306b73290 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.22e-04 | 165 | 32 | 3 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 166 | 32 | 3 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | 94c30d6ca179d0cb02a5ed0093c5a2871e17ae50 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 2.34e-04 | 168 | 32 | 3 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 169 | 32 | 3 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 169 | 32 | 3 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 171 | 32 | 3 | 5b74df72e36ad04dfb25c72f1ca8efe043f6cda6 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 171 | 32 | 3 | 4a2e6ea9674bf23e8012ef0bb2bf19ce1f55fcd5 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.47e-04 | 171 | 32 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 172 | 32 | 3 | 850e4c9e9003807c19695be4b13121b0808a9389 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-04 | 172 | 32 | 3 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.51e-04 | 172 | 32 | 3 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 172 | 32 | 3 | 018d8160cfcb7882475620dc678f48a69a0f643e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-04 | 175 | 32 | 3 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.69e-04 | 176 | 32 | 3 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-04 | 178 | 32 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | ef490b45901b2e6dedb519540fa3ae4e4db3a9ba | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 69f68eeab11b088fcb1f963c92eff0f1cd0e711a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | 797d165718dd1d819e65add3a7859f87b32238a5 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 180 | 32 | 3 | cea62fc006d68c3815c88bf17ec2617d7e41c3d2 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 181 | 32 | 3 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 181 | 32 | 3 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 2.91e-04 | 181 | 32 | 3 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.91e-04 | 181 | 32 | 3 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.91e-04 | 181 | 32 | 3 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 181 | 32 | 3 | c1203787cc3f968147fabdd3c646a04be96f6552 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 181 | 32 | 3 | f7258af89f4cc89446ff6754bdaa769320af95d6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.96e-04 | 182 | 32 | 3 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 183 | 32 | 3 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 183 | 32 | 3 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 184 | 32 | 3 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 184 | 32 | 3 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 3.11e-04 | 185 | 32 | 3 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 32 | 3 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.11e-04 | 185 | 32 | 3 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.11e-04 | 185 | 32 | 3 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 9245c322aae8bb9065d50dada198a5ee143a3444 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.11e-04 | 185 | 32 | 3 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.16e-04 | 186 | 32 | 3 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 186 | 32 | 3 | 903af26a63ec4b1755ab5cb81dfeb8dbd14bc5db | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 186 | 32 | 3 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 186 | 32 | 3 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 3.16e-04 | 186 | 32 | 3 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 3.21e-04 | 187 | 32 | 3 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 3.21e-04 | 187 | 32 | 3 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 187 | 32 | 3 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.21e-04 | 187 | 32 | 3 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 187 | 32 | 3 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.21e-04 | 187 | 32 | 3 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.21e-04 | 187 | 32 | 3 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 3.26e-04 | 188 | 32 | 3 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.26e-04 | 188 | 32 | 3 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.26e-04 | 188 | 32 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 3.26e-04 | 188 | 32 | 3 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 3.26e-04 | 188 | 32 | 3 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.26e-04 | 188 | 32 | 3 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.31e-04 | 189 | 32 | 3 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-04 | 189 | 32 | 3 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-04 | 189 | 32 | 3 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | d2b008f98739c6af7ee63b643011a240db20e4d8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.31e-04 | 189 | 32 | 3 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.31e-04 | 189 | 32 | 3 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 3.31e-04 | 189 | 32 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 189 | 32 | 3 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 3.31e-04 | 189 | 32 | 3 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.31e-04 | 189 | 32 | 3 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-04 | 189 | 32 | 3 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 3.31e-04 | 189 | 32 | 3 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 3.31e-04 | 189 | 32 | 3 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.31e-04 | 189 | 32 | 3 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.36e-04 | 190 | 32 | 3 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.78e-05 | 49 | 16 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | Clorocruoro Hem | 2.59e-05 | 123 | 32 | 4 | CID003518809 | |
| Drug | Br2BAPTA | 4.00e-05 | 7 | 32 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 4.00e-05 | 7 | 32 | 2 | CID009547999 | |
| Drug | lactosyl lysosphingolipid | 6.85e-05 | 9 | 32 | 2 | CID006439268 | |
| Drug | lysosphingomyelin | 7.24e-05 | 160 | 32 | 4 | CID000005263 | |
| Drug | R 478 | 1.04e-04 | 11 | 32 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.04e-04 | 11 | 32 | 2 | CID003081323 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 6236_UP | |
| Drug | CAS 298-57-7 | 1.47e-04 | 73 | 32 | 3 | CID000002761 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 6400_DN | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 5769_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 3726_DN | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 7491_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 6722_UP | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 1526_DN | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 6010_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 5751_UP | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 7228_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3311_DN | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 6206_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3281_DN | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 6272_UP | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 2841_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Down 200; 9uM; PC3; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 6688_DN | |
| Drug | Gvapspat amide | 1.99e-04 | 15 | 32 | 2 | CID000125015 | |
| Drug | cADPR | 2.07e-04 | 82 | 32 | 3 | CID000123847 | |
| Disease | unipolar depression, alcohol dependence | 8.34e-05 | 78 | 32 | 3 | EFO_0003761, MONDO_0007079 | |
| Disease | Anorectal Malformations | 9.10e-04 | 41 | 32 | 2 | C3495676 | |
| Disease | obesity | 2.24e-03 | 241 | 32 | 3 | EFO_0001073 | |
| Disease | age at initiation of smoking | 2.34e-03 | 66 | 32 | 2 | EFO_0021784 | |
| Disease | serum IgG glycosylation measurement | 2.37e-03 | 523 | 32 | 4 | EFO_0005193 | |
| Disease | common carotid intimal medial thickness | 2.41e-03 | 67 | 32 | 2 | EFO_0004860 | |
| Disease | information processing speed | 3.85e-03 | 85 | 32 | 2 | EFO_0004363 | |
| Disease | thyroid stimulating hormone measurement | 5.10e-03 | 323 | 32 | 3 | EFO_0004748 | |
| Disease | Beta blocking agent use measurement | 6.80e-03 | 114 | 32 | 2 | EFO_0009929 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GACWTEEKNKEKEKG | 491 | Q9BQT9 | |
| INSEKWDAGKGAKEK | 56 | Q8N7X0 | |
| WDAGKGAKEKDKTGK | 61 | Q8N7X0 | |
| GKGTVLQKAKEWEKK | 801 | Q8N4X5 | |
| AEEKKEEKTWKGSIG | 816 | Q8IY63 | |
| KDHKATNSKGSEWKK | 436 | Q9UGM1 | |
| TKEKGWRKSKGKKEE | 676 | Q5W041 | |
| KDAESSGCWGKKKKK | 801 | Q9UQB3 | |
| LKETDKEKGEVGKSW | 561 | Q15042 | |
| EKPEKKVKKSDCGEW | 36 | P21246 | |
| VEKSELWVDKKGSGK | 1121 | Q14573 | |
| KKKNSLKSWKGGKEE | 551 | Q6GQQ9 | |
| KYKEGWEKTKGKGFE | 546 | Q86VF7 | |
| DGTKKGREKEKAWEI | 3516 | Q5CZC0 | |
| EKAWKVKDEKSGKDD | 131 | Q2TBE0 | |
| DKEPEKSGKLWCAKK | 426 | Q8N3R9 | |
| SSKGKKGKKEKTEWL | 1171 | Q5VT06 | |
| KGKKEKTEWLDSFTG | 1176 | Q5VT06 | |
| KWKCKKEDESKGGYS | 176 | Q9NVM6 | |
| GKKSGRSKKWKEILT | 21 | P32298 | |
| KDAKLTGKKLWSSED | 261 | P54803 | |
| EEGSRKKRSGKWKNK | 1561 | Q5UIP0 | |
| TKGEPKWKASLKSEK | 171 | Q96NG3 | |
| KGKAQKSNKKWDGSE | 151 | O60841 | |
| EEDEGKGWSSEKVKK | 471 | P55201 | |
| KGWSSEKVKKAKAKS | 476 | P55201 | |
| ESTGDPKKKEYKEWK | 116 | Q9Y2B4 | |
| IWAKKKKLELESKGG | 2746 | Q15413 | |
| KGKKKVTWADLQGKE | 1871 | Q9HCK1 | |
| NSEDSSVGKGDWKKK | 136 | O94885 | |
| GLWGKKESKKKDEES | 476 | Q709C8 | |
| AKKKEKGLECSDWKP | 96 | O75764 | |
| SLKKGTKFVKWDDDS | 21 | Q9NQ66 | |
| GEWSGLEKNKKDGFK | 606 | Q9UPU5 | |
| DKLYKAGWEEEKKKG | 1781 | P20929 |